Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Robinson

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Drugs|November 1, 2021
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)Jason Bacharach, Andrew Tatham, Gloria Ferguson, et al.
Experimental Eye Research|September 20, 2005
A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonideMichael R Robinson, Susan S Lee, Hyuncheol Kim, et al.
Retina (Philadelphia, Pa.)|June 14, 2006
Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administrationHyuncheol Kim, Karl G Csaky, Luisa Gravlin, et al.
Pediatrics|February 3, 2006
Sarcoidosis in chronic granulomatous diseaseSuk See De Ravin, Nora Naumann, Michael R Robinson, et al.
American Journal of Ophthalmology|December 26, 2016
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical TrialRichard A Lewis, William C Christie, Douglas G Day, et al.
British Journal of Haematology|July 27, 2005
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertensionRoberto F Machado, Sabrina Martyr, Gregory J Kato, et al.
Experimental Eye Research|November 18, 2005
The pharmacokinetics of rituximab following an intravitreal injectionHyuncheol Kim, Karl G Csaky, Chi-Chao Chan, et al.
Investigative Ophthalmology & Visual Science|January 27, 2005
Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host diseaseHyuncheol Kim, Karl G Csaky, Brian C Gilger, et al.
Investigative Ophthalmology & Visual Science|March 23, 2011
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyesJoan-En Chang-Lin, James A Burke, Qing Peng, et al.
Investigative Ophthalmology & Visual Science|December 19, 2009
Vitreous VEGF clearance is increased after vitrectomySusan S Lee, Corine Ghosn, Zhiling Yu, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Drugs|November 1, 2021
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)Jason Bacharach, Andrew Tatham, Gloria Ferguson, et al.
Experimental Eye Research|September 20, 2005
A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonideMichael R Robinson, Susan S Lee, Hyuncheol Kim, et al.
Retina (Philadelphia, Pa.)|June 14, 2006
Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administrationHyuncheol Kim, Karl G Csaky, Luisa Gravlin, et al.
Pediatrics|February 3, 2006
Sarcoidosis in chronic granulomatous diseaseSuk See De Ravin, Nora Naumann, Michael R Robinson, et al.
American Journal of Ophthalmology|December 26, 2016
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical TrialRichard A Lewis, William C Christie, Douglas G Day, et al.
British Journal of Haematology|July 27, 2005
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertensionRoberto F Machado, Sabrina Martyr, Gregory J Kato, et al.
Experimental Eye Research|November 18, 2005
The pharmacokinetics of rituximab following an intravitreal injectionHyuncheol Kim, Karl G Csaky, Chi-Chao Chan, et al.
Investigative Ophthalmology & Visual Science|January 27, 2005
Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host diseaseHyuncheol Kim, Karl G Csaky, Brian C Gilger, et al.
Investigative Ophthalmology & Visual Science|March 23, 2011
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyesJoan-En Chang-Lin, James A Burke, Qing Peng, et al.
Investigative Ophthalmology & Visual Science|December 19, 2009
Vitreous VEGF clearance is increased after vitrectomySusan S Lee, Corine Ghosn, Zhiling Yu, et al.
Pageof 8